| 2-OADCs | 2-oxo dehydrogenase complex |
| AE2 | anion exchanger 2 |
| AMAs | antimitochondrial antibodies |
| ATRA | all-trans retinoic acid |
| Bas | bile acids |
| BDL | bile duct ligation |
| BECs | biliary epithelial cells |
| CCA | Cholangiocarcinoma |
| CCl4 | C-C Motif Chemokine Ligand 4 |
| dnTGFβRII | dominant-negative form of TGF-β receptor type II |
| ECM | secrete extracellular matrix |
| EMT | epithelial-to-mesenchymal transition |
| FUT2 | glycocalyx stabilising enzyme fucosyltransferase 2 |
| UDCA | ursodeoxycholic acid |
| FZD1 | Frizzled 1 |
| GWAS | genome-wide association study |
| HCC | hepatocellular carcinoma |
| Hes1 | hairy and enhancer of split-1 |
| Hh | Hedgehog |
| HLA | human leukocyte antigen |
| HNFs | hepatocyte nuclear factors |
| HSCs | hepatic stellate cells |
| IBD | inflammatory bowel disease |
| IFNg | interferon gamma |
| IL-12 | interleukin 12 |
| IL-6 | interleukin 6 |
| JAG2 | jagged canonical notch ligand 2 |
| JNKs | c-Jun N-terminal kinases |
| LRP5/6 | low-density lipoprotein receptor-related protein5/6 |
| MAIT | mucosal-associated invariant T cells |
| MRC | magnetic resonance cholangiography |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NTPD2 | ecto-ATPase nucleoside triphosphate diphosphohydrolase-2 |
| OCA | obeticholic acid |
| PBC | primary biliary cholangitis |
| PC | primary cilium |
| PDC-E2 | pyruvate dehydrogenase complex |
| PFs | portal fibroblasts |
| PLD | polycystic liver disease |
| PSC | primary sclerosing cholangitis |
| p75NTR | p75 neurotrophin receptor |
| SOX4 | SRY-box transcription factor 4 |
| SOX9 | SRY-box transcription factor 9 |
| TGF-β | transforming growth factor beta |
| TGR5 | Takeda G protein-coupled receptor 5 |
| TNF-α | tumour necrosis factor-α |
| UDCA | ursodeoxycholic acid |
| YAP1 | Yes-associated protein 1 |
| αSMA | α-smooth muscle actin |